Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.

Michael Camilleri Anthony J LemboRichard McCallumStavros TourkodimitrisLara KempsMatthew B MillerKirk BertelsenAlexandru Iacob

Published in: Alimentary pharmacology & therapeutics (2020)

Relamorelin showed acceptable safety and tolerability in phase 2 trials. Relamorelin may elevate blood glucose: this should be managed proactively in relamorelin-treated patients.

Keyphrases

blood glucose
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
type diabetes
clinical trial
peritoneal dialysis
glycemic control
open label
study protocol
randomized controlled trial
phase ii
big data
patient reported outcomes
patient reported